Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.
Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.
seqWell Inc. is a biotechnology company that specializes in gene sequencing and laboratory services, focusing on the development of innovative library preparation technology. Founded in 2014 and based in Beverly, Massachusetts, seqWell offers a range of products and services including paramagnetic beads for nucleic acid purification, library preparation kits, and customized bioinformatics support. Its technology platform facilitates simple and scalable multiplexing of hundreds to thousands of samples, eliminating the need for time-consuming normalization processes. The company markets its products through distributors in various countries, including the United States, Australia, South Korea, and several European nations, as well as through online channels. This approach enables seqWell to enhance the efficiency and consistency of DNA sequencing workflows for its clients.
Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and research. Founded in 2014, it provides a suite of diagnostic and discovery software that enables physicians, pharmaceutical companies, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. The flagship product, GENOMENON, automates the analysis of next-generation sequencing data, facilitating faster decision-making in cancer diagnosis and treatment, as well as in the study of inheritable diseases. By improving the efficiency of genomic interpretation, Genomenon aims to enhance patient outcomes and advance genetic research.
Manufacturer of liquid handling products intended to improve the lives of researchers and scientists everywhere. The company specializes in pipettes, laboratory instruments and compact pipettes that include a wirelessly connected iPad mini interface and big features in a small package, enabling researchers to get accurate, affordable, efficient, reliable and easy-to-use products.
PhenoVista Biosciences is a specialized contract research organization that focuses on high content imaging-based phenotypic assay development and screening services. The company utilizes advanced technology to conduct phenotypic screening feasibility, development, and extensive campaigns. With a team of experienced cell biologists, PhenoVista collaborates closely with clients to deliver timely and cost-effective data. The organization provides a variety of cell types and formats tailored for applications in neurobiology, oncology, metabolism, cell painting, and mitochondrial health, facilitating the development of innovative formulations and offering valuable insights into diseases using human cell models.
Accelix is a biotechnology company that helps cell and gene therapy companies to meet their key product QC requirements. It provides an instrument and a room temperature stable cartridge to gather multi-parameter results. The company was founded in 2007 and headquartered in Yerushalayim, Israel.
Private Equity Round in 2021
Gemini Bio-Products manufactures biological products and chemical reagents for the cell culture community globally. It offers cell culture sera, such as fetal bovine, specialized fetal bovine, other non-fetal, human and animal sera; custom and specialized media; and supplements and reagents, including amino acids, antibiotics and antimycotics, culture supplements and albumins, recombinant proteins, attachment factors, and cell dissociation reagents.
PBS Biotech, Inc. specializes in the production of advanced single-use bioreactors tailored for the pharmaceutical industry. These bioreactors are designed to create homogeneous and scalable mixing conditions, making them suitable for various sensitive cell therapy products and cell culture applications. The company offers disposable vessels and bags, alongside research and process development services, including cell therapy optimization, characterization, and risk analysis. By providing efficient and cost-effective systems, PBS Biotech aims to help clients navigate complex cell culture challenges, ultimately enhancing operational efficiency and reducing costs across different stages of the cell culture process, from research and development to clinical and commercial manufacturing.
KromaTiD, Inc. is an early-stage bioscience company based in Fort Collins, Colorado, established in 2007. The company specializes in chromosome analysis products aimed at advancing the understanding of genetic abnormalities and diseases. KromaTiD develops molecular cytogenetic assays and reagents, including its proprietary Directional Genomic Hybridization (dGH) technology, which enhances standard fluorescence in situ hybridization (FISH) assays. These tools enable researchers to discover, detect, and diagnose various disease-causing mutations, such as inversions and translocations, from single cells. KromaTiD’s offerings include assays for targeting entire chromosomes or individual chromatids, inversion detection solutions, and custom assays covering the entire human genome. Their products are designed to support biomedical research and medical testing applications, facilitating advancements in oncology and rare diseases, and assisting research teams in academia and the biopharma sector in developing novel therapeutics.
Genomenon, Inc. is a software development company based in Ann Arbor, Michigan, that specializes in tools for genetic diagnosis and research. Founded in 2014, it provides a suite of diagnostic and discovery software that enables physicians, pharmaceutical companies, and researchers to quickly and accurately identify disease-causing variants from genomic-sequencing datasets. The flagship product, GENOMENON, automates the analysis of next-generation sequencing data, facilitating faster decision-making in cancer diagnosis and treatment, as well as in the study of inheritable diseases. By improving the efficiency of genomic interpretation, Genomenon aims to enhance patient outcomes and advance genetic research.
Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.
Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.
seqWell Inc. is a biotechnology company that specializes in gene sequencing and laboratory services, focusing on the development of innovative library preparation technology. Founded in 2014 and based in Beverly, Massachusetts, seqWell offers a range of products and services including paramagnetic beads for nucleic acid purification, library preparation kits, and customized bioinformatics support. Its technology platform facilitates simple and scalable multiplexing of hundreds to thousands of samples, eliminating the need for time-consuming normalization processes. The company markets its products through distributors in various countries, including the United States, Australia, South Korea, and several European nations, as well as through online channels. This approach enables seqWell to enhance the efficiency and consistency of DNA sequencing workflows for its clients.
InFuse Holdings operates high-quality, cost-effective ambulatory infusion centers. The infrastructure in the US for infusion therapies is lacking and, in most communities today, infusions centers have a wide range of cost and quality. InFuse Holdings brings best practices – in the workflow, inventory management, scheduling, safety protocols, staffing, customer experience, and outcomes data collection and reporting – to provide patients with a convenient, safe, and caring environment. The ambulatory infusion center model allows InFuse to provide these services at a lower cost than other delivery channels, helping to decrease the overall cost of healthcare for patients, employers, and payors.
SGI-DNA provides a variety of synthetic genomic solutions to advance your research. Our comprehensive suite of genomic services will allow you to discover, design, and build the sequences you need. We are committed to reducing barriers associated with DNA synthesis and sequence analysis by leveraging the technology developed at the J. Craig Venter Institute and Synthetic Genomics, Inc. SGI-DNA, a wholly owned subsidiary of Synthetic Genomics, Inc (SGI), was founded in 2013 and is headquartered in La Jolla, CA. Building on the scientific advancements and breakthroughs from leading scientists such as J. Craig Venter, Ham Smith, Clyde Hutchison, Dan Gibson and their teams, SGI-DNA utilizes unique and proprietary DNA technologies to produce complex synthetic genes and reagents. SGI-DNA also offers a comprehensive suite of genomic services, including whole genome sequencing, library design, and other bioinformatics services. SGI-DNA is responsible for all commercial aspects of SGI’s synthetic DNA business and focuses on strategic business relationships with both academic and commercial researchers.
Halo Labs (formerly Optofluidics) is a venture backed scientific instrumentation company that commercializes high throughput biopharmaceutical quality control tools using the latest optics, image processing and microfluidics.
Our investors and development partners include BioAdvance, the National Science Foundation, the Defense Advanced Research Projects Agency, and the Ben Franklin Technology Partners. In 2012 Optofluidics was named Philadelphia Life Sciences startup of the year.
BioInformatics, LLC is a market research and advisory firm that serves the life science, medical device, pharmaceutical, and diagnostic industries. The company specializes in both primary and secondary research, providing insights on market size, attractiveness, and product optimization. Key services include product concept testing, pricing strategy analysis, customer satisfaction assessments, and brand strength evaluations. BioInformatics helps clients navigate corporate acquisitions and measure brand loyalty, offering tailored research that informs strategic decisions. With a multidisciplinary team of industry veterans and research experts, the firm supports clients in enhancing their market positioning and developing effective marketing strategies. Founded in 1994 and based in Arlington, Virginia, BioInformatics caters to a diverse clientele, including biotechnology firms, medical diagnostics companies, and professional service providers.
MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes. MedCision’s digitally enabled ThawSTAR® Automated Cell Thawing Systems are designed to replace uncontrolled and highly variable manual methods, de-risking the therapeutic cell thawing process and optimizing cell efficacy. An industry first, ThawSTAR systems optimize cell thawing using a customizable algorithm for each unique cell therapy product and protocol. These systems, combined with MedCision’s ultra-low temperature cold storage and transport solutions, advance near-patient drug management by providing controlled and scalable processing of temperature-sensitive biotherapeutic products.
LabConnect, LLC specializes in providing central laboratory services for the biopharmaceutical industry. The company offers a wide range of routine and specialized testing services, including clinical chemistry, hematology, molecular diagnostics, and oncology, among others. It also provides pathology services, biostorage, sample tracking, and logistics support. LabConnect is equipped with advanced technology and operates multiple laboratories across the United States and internationally, including locations in Europe, South America, and Asia. Additionally, the company offers a software platform called BioVisualization, which enables real-time analysis of clinical sample data. Founded in 2002 and based in Johnson City, Tennessee, LabConnect has established a strategic collaboration with Symphony Clinical Research to enhance its service offerings for drug development and clinical research organizations.
Empire Genomics, LLC specializes in genomic technologies that facilitate genome-wide analyses to uncover the mechanisms behind diseases. The company offers a range of products including fluorescence in situ hybridization (FISH) probes—custom, solid tumor, and control probes—as well as BAC clones. In addition, Empire provides clinical testing services encompassing flow cytometry, cytogenetics, and next generation sequencing (NGS), along with cancer genetics testing that incorporates various techniques such as PCR and microarrays. The company’s comprehensive molecular and cytogenetic diagnostic platform is designed to improve the accuracy of diagnoses and enhance personalized treatment options for patients with cancer and other complex conditions. Empire Genomics operates through global distributors and an online store, and maintains strategic partnerships with organizations like Life Technologies and ICON. Founded in 2006, the company is headquartered in Buffalo, New York, with an additional office in Williamsville, New York.
Rubicon Genomics, Inc. is a biotechnology company based in Ann Arbor, Michigan, specializing in nucleic acid library preparation and amplification technologies for clinical research applications. Founded in 2000 by University of Michigan faculty members, the company focuses on developing innovative products that enhance the sensitivity of DNA analysis. Its product lineup includes the ThruPLEX and PicoPLEX kits, which utilize ligation-based and quasi-random primed amplification methods, respectively. These products enable the analysis of small amounts of DNA from various sources, including plasma and tissue samples. Rubicon's technologies are particularly notable for their ability to detect DNA methylation patterns associated with cancer, facilitating non-invasive diagnostic tests that can aid physicians in identifying diseases. The company markets its products both directly and through distributors, emphasizing its commitment to advancing human genetics into practical medical applications while supporting the local economy. Rubicon Genomics operates as a subsidiary of Takara Bio USA Holdings, Inc.
Diagnostic BioSystems Inc. specializes in enhancing immunohistochemistry results by offering innovative anatomic pathology reagents and systems. The company focuses on providing high-quality products and exceptional customer service. It serves the anatomic pathology and histology markets through direct sales in the domestic market and via international distributors in over 60 countries. Diagnostic BioSystems' product portfolio includes primary and FITC antibodies, autostainers, chromogens, detection kits, and various ancillary products, all designed to support the practice of pathology and improve diagnostic accuracy. Additionally, the company manufactures medical devices to complement its offerings.
BioCision is a biotechnology company focused on standardizing pre-analytical sample handling and improving laboratory procedures. The company develops innovative products designed to eliminate variability in common laboratory practices, thereby enhancing the integrity of temperature-sensitive therapeutics, biological samples, and biomaterials. BioCision's offerings include the CoolRack®, CoolSink™, and ThermalTray™ for temperature standardization, the CoolBox™ for ice-free benchtop cooling, the CoolCell® for alcohol-free cell freezing, and various TruCool™ accessories and consumables. These products are utilized globally by leading institutions in the biotech, pharmaceutical, clinical, diagnostic, academic, and government sectors, aiding researchers in the successful discovery and development of therapeutics.